Recommendations by the DOG for the planning of clinical trials on behalf of third parties
Crossref DOI link: https://doi.org/10.1007/s00347-018-0781-2
Published Online: 2018-09-06
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Text and Data Mining valid from 2018-09-06
